Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AUTO4 in Relapsed or Refractory TRBC1 Positive T Cell Non-Hodgkin Lymphoma
NCT03590574Phase 2Terminated
- Sponsor
- Autolus Therapeutics plc
- Start
- Aug 2018
- Primary completion
- Dec 2024
- Modality
- CAR-T Cells
- Countries
- 2
01
Overview
A Phase 2 trial of AUTO4 in T-cell non-Hodgkin lymphoma, sponsored by Autolus Therapeutics plc. Started Aug 2018; status: terminated.
02
Drugs
AUTO4
03
Conditions
T-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT03590574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03590574.